Court stands by the 2015 Risperdal verdict amount

  • Court stands by the 2015 Risperdal verdict amount

In early 2015, a Philadelphia jury had passed a verdict of $2.5 million in damages to be paid to a Risperdal plaintiff which was also the first verdict for the antipsychotic drug Risperdal's alleged side effect of abnormal breast growth in males, stating that the defendant failed to warn about the risks involved. Following this, the defendant, J&J's Janssen Pharmaceutical's, filed a motion seeking a new trial which was upheld by a judge in Philadelphia. Most of the Risperdal cases are pending in the Philadelphia Court of Common Pleas in Pennsylvania, where a small group of cases is being heard as a part of bellwether trial process and a handful of Risperdal settlements have been reached in certain cases. At least 13,800 Risperdal lawsuits are filed against J&J nationwide.


We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

Hurricane Relief Fund
We donated to Hurricane Relief Fund and got a signed ball from Kareem Abdul-Jabbar, the greatest
AAJ Annual Convention 2017
Neural IT sponsored TRT meeting was one of the active participants of AAJ Annual Convention 2017.
NJAJ Boardwalk Seminar 2017
Neural IT exhibited at the NJAJ Boardwalk Seminar 2017 held at Harrah's Resort, Atlantic City, NJ

Latest Tweets